Literature DB >> 17717512

Outbreaks of respiratory illness mistakenly attributed to pertussis--New Hampshire, Massachusetts, and Tennessee, 2004-2006.

.   

Abstract

Pertussis, or whooping cough, is a highly infectious, nationally notifiable respiratory disease associated with prolonged cough illness and paroxysms of coughing, inspiratory "whoop," or posttussive vomiting. Reported pertussis cases have tripled in the United States since 2001, with 25,616 probable or confirmed cases reported in 2005. This increase has been attributed to increased circulation of Bordetella pertussis, waning vaccine-induced immunity among adults and adolescents, heightened awareness of pertussis among health-care providers, increased public health reporting, and increased use of polymerase chain reaction (PCR) testing for diagnosis. To minimize the spread of pertussis, control measures must be implemented early in the course of illness when the risk for transmission is highest. However, diagnosis of pertussis is complicated by nonspecific signs and symptoms, particularly in the early catarrhal stage of disease. In addition, the lack of rapid, sensitive, and specific laboratory tests makes early and accurate identification of pertussis challenging. This report describes two hospital outbreaks and one community outbreak of respiratory illness during 2004-2006 in New Hampshire, Massachusetts, and Tennessee that were attributed initially to pertussis. However, subsequent investigations revealed negative or equivocal laboratory results and epidemiologic and clinical features atypical of pertussis, suggesting that pertussis was not the cause of these outbreaks. The findings in this report underscore the need for thorough epidemiologic and laboratory investigation of suspected pertussis outbreaks when considering extensive control measures.

Entities:  

Mesh:

Year:  2007        PMID: 17717512

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  24 in total

1.  Multicenter Clinical Evaluation of the Automated Aries Bordetella Assay.

Authors:  Ryan F Relich; Amy Leber; Stephen Young; Ted Schutzbank; Ronald Dunn; Janet Farhang; Timothy S Uphoff
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Aerosolized vaccine as an unexpected source of false-positive Bordetella pertussis PCR results.

Authors:  Hossein Salimnia; Paul R Lephart; Basim I Asmar; Dawn Prebelich; Erin Paulson; Marilynn R Fairfax
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 3.  Towards improved accuracy of Bordetella pertussis nucleic acid amplification tests.

Authors:  Michael Loeffelholz
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

4.  Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests.

Authors:  Angela M Caliendo; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2016-01-20       Impact factor: 5.948

5.  Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis.

Authors:  Andrew L Baughman; Kristine M Bisgard; Margaret M Cortese; William W Thompson; Gary N Sanden; Peter M Strebel
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

Review 6.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

7.  Evaluation of a multitarget real-time PCR assay for detection of Bordetella species during a pertussis outbreak in New Hampshire in 2011.

Authors:  Fengxiang Gao; Jennifer C Mahoney; Elizabeth R Daly; Wendy Lamothe; Daniel Tullo; Christine Bean
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

8.  Identification and evaluation of new target sequences for specific detection of Bordetella pertussis by real-time PCR.

Authors:  William S Probert; Janet Ely; Kimmi Schrader; Jessica Atwell; Angela Nossoff; Stanley Kwan
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

9.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

10.  Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.

Authors:  Jamie N Sutherland; Christine Chang; Sandra M Yoder; Michael T Rock; Jennifer A Maynard
Journal:  Clin Vaccine Immunol       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.